0000000001316791
AUTHOR
Robin Gustafsson
Peer interaction and pioneering organizational form adoption : A tale of the first two for-profit stock exchanges
Building on a historical case study on the first two stock exchanges to adopt the now globally dominant for-profit organizational form, the Stockholm Stock Exchange in 1993 and the Helsinki Stock Exchange in 1995, we argue that interaction among socially proximate peers contributes to pioneering organizational form adoption within an industry, particularly when such forms are introduced by established organizations. Peer interaction can induce a search for technically efficient organizational forms through the sharing of collective experiences, the establishment of collective assumptions, and a joint search for solutions. Together, these factors contribute to the legitimization of novel or…
Human and organizational factors in European nuclear safety: A fifty-year perspective on insights, implementations, and ways forward
Abstract In this essay we investigate the “lessons learned” within the domain of human and organizational factors (HOF) from operating European nuclear power plants (NPPs) in a fifty-year perspective. Specifically, we consider learning processes at an industry level that aim at promoting human contributions to nuclear safety. This is done by bringing together two main perspectives: (1) a historical perspective on HOF-related institutional and research initiatives is presented by outlining the history of nuclear safety according to three major nuclear accidents, (2) an applied perspective is provided on how HOF are managed in the field. This latter perspective rests on the results of the EU …
A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction
Background: Oral activated factor XI (FXIa) inhibitors may modulate coagulation to prevent thromboembolic events without substantially increasing bleeding. We explored the pharmacodynamics, safety, and efficacy of the oral FXIa inhibitor asundexian for secondary prevention after acute myocardial infarction (MI). Methods: We randomized 1601 patients with recent acute MI to oral asundexian 10, 20, or 50 mg or placebo once daily for 6 to 12 months in a double-blind, placebo-controlled, phase 2, dose-ranging trial. Patients were randomized within 5 days of their qualifying MI and received dual antiplatelet therapy with aspirin plus a P2Y12 inhibitor. The effect of asundexian on FXIa inhibition…
sj-xlsx-1-oss-10.1177_01708406211024570 – Supplemental material for Peer Interaction and Pioneering Organizational Form Adoption: A tale of the first two for-profit stock exchanges
Supplemental material, sj-xlsx-1-oss-10.1177_01708406211024570 for Peer Interaction and Pioneering Organizational Form Adoption: A tale of the first two for-profit stock exchanges by Zeerim Cheung, Robin Gustafsson and Rasmus Nykvist in Organization Studies